Press Releases Biotest AG Deutsche Boerse AG

Equities

BIO3

DE0005227235

Real-time Estimate Tradegate Other stock markets 04:30:00 2024-05-15 EDT			5-day change	1st Jan Change
27.7 ^EUR	+0.36%		-0.72%	-11.04%

05-07	Biotest Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-19	Biotest Launches New Plasma Collection Center in Germany	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biotest : Speech of Peter Janssen - German Version	05-08	PU
Biotest AG: Annual General Meeting approves dividend distribution	05-07	EQ
Biotest increased sales by 83.6% to Euro 215.2 million in first quarter 2024	05-07	EQ
Biotest AG opens 12th plasma collection centre in Germany	04-19	EQ
Biotest AG increased sales by 32% in the financial year 2023	03-28	EQ
Biotest : Sustainability report Declaration of compliance 2023	03-28	PU
Biotest : Invitation / Agenda of Annual General Meeting 2024	03-25	PU
Biotest : Notes on agenda item 1 - German Version	03-24	PU
Biotest achieves EBIT forecast for 2023	02-29	EQ
Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care	02-28	EQ
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate	02-14	EQ
AFR: Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	01-30	EQ
AFR: Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	01-22	EQ
Biotest AG opens 11th plasma collection centre in Germany	01-18	EQ
AFR: Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	01-11	EQ
Biotest expands its clinical development program for trimodulin to patients with community-acquired pneumonia (CAP)	12-12	EQ
Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation	11-28	EQ
Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023	11-02	EQ
Biotest AG: Increase of the EBIT guidance	23-10-05	EQ
Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG	23-10-05	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Biotest AG Deutsche Boerse AG

Equities

BIO3

DE0005227235

Press Releases

Filters